GLP-1/CD98HC Antibody Fusion Protein (4B Technologies)

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameGLP-1/CD98HC Antibody Fusion Protein (4B Technologies)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Amino acid transporter heavy chain SLC3A2Glucagon-like peptide 1 receptor agonists
TargetsAmino acid transporter heavy chain SLC3A2Glucagon-like peptide 1 receptor
Therapy Area/IndicationsMental DisordersNerve DegenerationEndocrine System Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator Companies4b Technologies (Suzhou) Ltd
China Registration ClassN/A

Develop Information

Active Companies4b Technologies (Suzhou) Ltd
Inactive CompaniesN/A
Active IndicationsMental DisordersNerve DegenerationEndocrine System Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A